1984
DOI: 10.1126/science.6505679
|View full text |Cite
|
Sign up to set email alerts
|

Inhibitors of Lysosomal Enzymes: Accumulation of Lipofuscin-Like Dense Bodies in the Brain

Abstract: Injections of leupeptin (a thiol proteinase inhibitor) or chloroquine (a general lysosomal enzyme inhibitor) into the brains of young rats induced the formation of lysosome-associated granular aggregates (dense bodies) which closely resembled the ceroid-lipofuscin that accumulates in certain disease states and during aging. The dense material increased in a dose- and time-dependent fashion and was differentially distributed across brain regions and cell types. These observations provide clues to the origins of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

9
95
1

Year Published

1986
1986
2018
2018

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 266 publications
(105 citation statements)
references
References 19 publications
9
95
1
Order By: Relevance
“…There is the formation of lipofuscin-like lipopigments in rat hepatocytes and other internal organs, such as kidneys, following an intraperitoneal administration of protease inhibitors, such as leupeptin (Ivy et al , 1991a. This observation strongly supports the idea that the perturbation of protein degradation and its intracellular disposition in secondary lysosomes is a fundamental mechanism for lipofuscinogenesis, as Ivy initially proposed for brain cells 20 years ago (Ivy et al 1984). At the same time, this observation strongly suggests that a decrease in proteolysis during aging leads to progressive decreases in turnovers of intracellular proteins, including enzyme molecules.…”
Section: What Really Declines With Age?supporting
confidence: 59%
“…There is the formation of lipofuscin-like lipopigments in rat hepatocytes and other internal organs, such as kidneys, following an intraperitoneal administration of protease inhibitors, such as leupeptin (Ivy et al , 1991a. This observation strongly supports the idea that the perturbation of protein degradation and its intracellular disposition in secondary lysosomes is a fundamental mechanism for lipofuscinogenesis, as Ivy initially proposed for brain cells 20 years ago (Ivy et al 1984). At the same time, this observation strongly suggests that a decrease in proteolysis during aging leads to progressive decreases in turnovers of intracellular proteins, including enzyme molecules.…”
Section: What Really Declines With Age?supporting
confidence: 59%
“…Intraventricular infusions of the broad-spectrum serine and cysteine protease inhibitor leupeptin and the cysteine protease inhibitor E-64c resulted in a general accumulation of dense granular aggregates throughout rodent brains, as well as in the retina and internal organs, thereby partially reproducing features of NCLs, Alzheimer's disease, and aging (41). Several in vitro studies using cultured hippocampal and cortical slices (42,43) or cardiac myocytes (44) appeared to reproduce the in vivo experiments.…”
Section: Discussionmentioning
confidence: 78%
“…Alterations in the last step of autophagy—the degradation of cargo in the lysosomal lumen (Hayasaka, 1989; Ivy, Schottler, Wenzel, Baudry & Lynch, 1984; Nakano, Oenzil, Mizuno & Gotoh, 1995; Tauchi, Hananouchi & Sato, 1980)—and reduced autophagosome/lysosome fusion have both shown to contribute to autophagic failure in the old liver (Terman, 1995). Although the extensive changes in the lipid composition of intracellular membranes reported in old cells (Kitani, 1999; Rottem & Greenberg, 1975) lead to the proposal that reduced vesicle fusogenicity was behind autophagosome maturation, our studies with isolated autophagosomes and lysosomes reveal that fusion between these two compartments is actually enhanced and not reduced.…”
Section: Discussionmentioning
confidence: 99%